Clinical Practice Guideline for Management of Tinnitus: Recommendations From the US VA/DOD Clinical Practice Guideline Work Group [0.03%]
耳鸣管理临床实践指南：来自美国退伍军人事务部/国防部临床实践指南工作组的建议
LaGuinn P Sherlock,Jennifer Ballard-Hernandez,Amy Boudin-George et al.
LaGuinn P Sherlock et al.
Importance: The most recent US clinical practice guideline (CPG) for tinnitus was published in 2014. The US Department of Veterans Affairs (VA)/US Department of Defense Tinnitus Clinical Practice Guideline Work Group rece...
Over-the-Counter Hearing Aid-Enabled Earbuds-Merging Hearing Health and Technology [0.03%]
非处方助听耳机：听力健康与科技的融合
Alexander Chern,Justin S Golub
Alexander Chern
Derek J Lam
Derek J Lam
High Sugar-Sweetened Beverage Intake and Oral Cavity Cancer in Smoking and Nonsmoking Women [0.03%]
高含糖饮料摄入量与女性吸烟者和非吸烟者的口腔癌关系研究
Luis Gomez-Castillo,Kara L Cushing-Haugen,Mateo Useche et al.
Luis Gomez-Castillo et al.
Importance: The incidence of oral cavity cancer (OCC) is increasing among nonsmokers and young individuals without traditional risk factors worldwide. High sugar-sweetened beverage (SSB) intake is associated with various ...
A Framework for Clinical Trials in Hereditary Hemorrhagic Telangiectasia-Associated Epistaxis-Navigating the PATH [0.03%]
遗传性出血性毛细血管扩张症相关鼻出血的临床试验框架-PATH指南
Andrew M Peterson,Murali M Chakinala,Jay F Piccirillo
Andrew M Peterson
Shaun Edalati,Tony Chung,Maya Govindaraj et al.
Shaun Edalati et al.
Objective: To characterize trends in otolaryngology (ear, nose, and throat [ENT]) retractions, identify underlying causes, and compare retraction rates with similar specialties. ...
Pretreatment Liquid Biopsy and Clinicopathologic Features in HPV-Associated Oropharyngeal Squamous Cell Carcinoma [0.03%]
与HPV相关的口腔咽部鳞状细胞癌的治疗前液体活检和临床病理特征
Peter V Cooke,Susmita Chennareddy,Daniel O Kraft et al.
Peter V Cooke et al.
Importance: Despite the favorable prognosis for HPV-positive oropharyngeal squamous cell carcinoma (HPV+ OPSCC), efforts to de-escalate treatment intensity, while maintaining low recurrence and mortality rates, have prove...
Current Progress and Future Directions of Immunotherapy in Head and Neck Squamous Cell Carcinoma: A Narrative Review [0.03%]
头颈部鳞状细胞癌免疫治疗的现状和未来方向：叙事综述
Edward S Sim,Hoang C B Nguyen,Glenn J Hanna et al.
Edward S Sim et al.
Importance: For decades, the 3 therapeutic pillars for head and neck squamous cell carcinoma (HNSCC) have been radiation therapy, chemotherapy, and surgery. In recent years, a fourth pillar, immunotherapy, has shifted the...